Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the University of Ghana and Oxford University, including researchers from Oxford Population Health’s Health Economics Research Centre, have shown that small cash incentives increased COVID-19 vaccine uptake in rural Ghana. The findings, published in Nature Medicine, could offer a new strategy for enhancing health interventions in Africa.

The recent COVID-19 pandemic highlighted the challenges associated with implementing vaccination campaigns equitably. There were significantly lower vaccination rates in African countries than the rest of the world (41 COVID-19 vaccine doses per 100 population, compared to 154 for the rest of the world by 4 July 20221), despite adequate supplies in many countries.

Previous studies in Europe and North America have shown that cash incentives increase vaccination rates. So, the research team sought to understand whether cash incentives could have improved COVID-19 vaccination uptake and narrowed the vaccination gap between Africa and the rest of the world.

Read the full story on the Oxford Population Health website

Similar stories

Interview with Diagnostics in Tropical and Infectious Diseases(DiTi) award recipient Dr Christopher Chew

Global Health research at Oxford University and its partners is broad reaching, bringing significant impact across all academic disciplines of medicine, the physical and life sciences, social sciences and humanities. The Diagnostics in Tropical and Infectious Disease (DiTi) award aims to strengthen the long-term partnership between Oxford University and Mahidol University by establishing partnerships and supporting collaborative projects to develop diagnostic devices for tropical and infectious diseases, with the goal of driving more translational research initiatives in global health. Read this interview from award winner Dr Chris Chew.